Basaksehir Cam Sakura City Hospital
Istanbul, Turkey (Türkiye)
NCT Number: NCT06430619
This study aims to determine the cut-off values of the new oxygenation indices and further investigate their capabilities in diagnosing ARDS and predicting its severity in ICU. Additionally, the investigators aim to compare these results with conventional oxygenation and saturation indices.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Istanbul, Turkey (Türkiye)
Recent studies have shown that mechanical power (MP) values below 17 J/min and driving pressure (DP) values below 15 cmH2O reduce intensive care unit (ICU) mortality. Asar et al. have introduced six new oxygenation indices utilizing MP and DP instead of Pmean (OSI-MPtot, OI-MPtot, OSI-ΔPinsp, OI-ΔPinsp, OSI-MPdyn, OI-MPdyn). They compared the predictive abilities of these new indices for ICU mortality in Covid-ARDS (C-ARDS) patients with conventional oxygenation indices (P/F, SpO2/FiO2, OI, OSI, PaO2/(FiO2xPEEP), and SpO2/FiO2xPEEP). OI-ΔPinsp, OSI-ΔPinsp, and OSI-MPdyn indices exhibited the highest predictive power for ICU mortality. However, cut-off values for the diagnosis and severity determination (mild, moderate, and severe) of ARDS patients have not been investigated.
In this study, our objective is to determine the cut-off values of the new oxygenation indices and further investigate their capabilities in diagnosing ARDS and predicting its severity in ICU. Additionally, the investigators aim to compare these results with conventional oxygenation and saturation indices.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: During 28 days in the intensive care unit
It was aimed to compare the oxygenation indexes of the patients. It will be examined which of these indices is more effective in diagnosing ARDS.
Time frame: During 28 days in the intensive care unit
It was aimed to compare the sequential organ failure assessment scores of the patients.
Score ranges from 0 (best outcome) to 24 (worst outcome) points.
Time frame: During 28 days in the intensive care unit
It was aimed to compare the acute physiology and chronic health evaluation-II scores of the patients.
Score ranges from 0 (best outcome) to 71 (worst outcome) points.
Time frame: During 28 days in the intensive care unit
It was aimed to compare the Charlson comorbidity index scores of the patients. Based on the Charlson comorbidity index score, the severity of comorbidity was categorized into three grades: mild, with Charlson comorbidity index scores of 1-2; moderate, with Charlson comorbidity index scores of 3-4; and severe, with Charlson comorbidity index scores ≥5.
Time frame: During 28 days in the intensive care unit
It was aimed to compare the Charlson comorbidity index of the patients.
Time frame: During 28 days in the intensive care unit
It was aimed to compare the pH of the patients.
Time frame: During 28 days in the intensive care unit
It was aimed to compare the base excess of the patients.
Time frame: During 28 days in the intensive care unit
It was aimed to compare the lactate of the patients.
Time frame: During 28 days in the intensive care unit
It was aimed to compare the partial oxygen pressure of the patients.
Başakşehir Çam & Sakura City Hospital
Other Gov
New Criteria for Classifying Acute Respiratory Distress Syndrome Severity Using a Machine Learning Approach: Novel Oxygenation and Saturation Indices
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04582201
Lung Diseases, Respiration Disorders
Santa Monica, California, United States
View Trial DetailsNCT03818854
Lung Diseases, Respiration Disorders
Sacramento, California, United States
View Trial DetailsNCT02273687
Disease Attributes, Emergencies
Nîmes, France
View Trial DetailsNCT01743105
Disease Attributes, Emergencies
Nîmes, Gard, France
View Trial Details